Small personalized vaccine trial sees progress in late-stage kidney cancer – Endpoints News

All nine late-stage kid­ney can­cer pa­tients in a Phase 1 tri­al of a per­son­al­ized vac­cine re­mained can­cer-free af­ter about three years of re­ceiv­ing treat­ment, re­searchers …Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas
© Endpoints News 2025If you’re already an Endpoints subscriber, enter your email below for a
magic link that lets you log in quickly without using a password. Please note the magic link is
one-time use only and expires after 24 hours.We’ll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.Sign up for free to read a limited number of articles each month.Pick what newsletters get delivered to your inbox each week.Biopharma
ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week
Healthcare
ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week
Want unlimited access? Sign up for a premium subscription plan.

Source: https://endpts.com/small-personalized-vaccine-trial-sees-progress-in-late-stage-kidney-cancer/